Cantor Fitzgerald Comments on XENE FY2026 Earnings
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Xenon Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the biopharmaceutical company will post earnings of ($3.58) per share for the year. […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Xenon Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the biopharmaceutical company will post earnings of ($3.58) per share for the year. […]
